Biomarker distribution after injection into the canine prostate: implications for gene therapy

Area of Science:

• Veterinary Medicine
• Molecular Biology
• Biomaterials Science

Background:

• Transrectal injection is a common method for delivering therapeutics to the prostate.
• Understanding biomarker distribution is crucial for effective gene therapy in the prostate.
• Viral vectors offer potential for targeted gene delivery but their distribution can be limited.

Purpose of the Study:

• To assess the distribution of biomarkers following transrectal injection into the canine prostate.
• To investigate methods for improving gene expression distribution from viral vectors in the prostate.
• To compare fluid-phase versus solid-carrier delivery of viral vectors for gene expression.

Main Methods:

• Histopathological evaluation of carbon black distribution via transurethral, transperineal, and transrectal routes in canine prostates.
• Comparison of gene expression distribution from canarypox virus (ALVAC) vector delivered in fluid-phase versus a gelatine sponge matrix.
• Quantification of beta-galactosidase gene expression following transrectal delivery of ALVAC vector.

Main Results:

• Transurethral administration showed scattered carbon black in ducts and acini, primarily peripherally.
• Direct transrectal injection resulted in localized carbon black and minimal peri-acinar distribution.
• Fluid-phase ALVAC vector delivery showed limited gene expression at the injection site and needle track.
• Delivery of ALVAC vector within a gelatine sponge matrix resulted in qualitatively greater gene expression.

Conclusions:

• Transrectal injection of fluid-phase biomarkers, including viral vectors, leads to highly localized gene expression in the canine prostate.
• Utilizing a gelatine sponge matrix for viral vector delivery significantly enhances the distribution and spread of gene expression.
• This study highlights a promising strategy for improving the efficacy of gene therapy in prostate applications.